AcouSort AB (publ)

Stockholm Stock Exchange ACOU.ST

AcouSort AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 2.18 M

AcouSort AB (publ) Net Cash Used Provided By Financing Activities is USD 2.18 M for the year ending December 31, 2023, a 0.00% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • AcouSort AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
  • AcouSort AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 3.92 M, a 177.87% change year over year.
  • AcouSort AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 1.41 M, a 0.00% change year over year.
  • AcouSort AB (publ) Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 0.00, a -100.00% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: ACOU.ST

AcouSort AB (publ)

CEO Mr. Torsten Freltoft
IPO Date Dec. 14, 2020
Location Sweden
Headquarters Building 406
Employees 17
Sector Healthcare
Industries
Description

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.

Similar companies

AAC.ST

AAC Clyde Space AB (publ)

USD 3.99

-1.23%

SUS.ST

Surgical Science Sweden AB (publ)

USD 15.07

-2.83%

ALZ.ST

Alzinova AB (publ)

USD 0.25

-3.82%

StockViz Staff

February 5, 2025

Any question? Send us an email